pembrolizumab Archives

Merck | MSD Exhibition booth at the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Peter Hofland, Ph.D - June 24, 2020

Seattle Genetics. Exhibition booth during the 2019 annual meeting of the American Society of Medical Oncology (ASCO). In the back of the booth the enfortumab vedotin presentation.

Potential Accelerated Approval Enfortumab Vedotin + Pembrolizumab in Metastatic Urothelial Cancer

Peter Hofland, Ph.D - April 2, 2020

Combination Enfortumab Vedotin + Pembrolizumab Granted Breakthrough Therapy in Bladder Cancer

Peter Hofland, Ph.D - February 19, 2020

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of Bladder...

Peter Hofland, Ph.D - February 11, 2020

Doctor discussing treatment options with a patient.

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Andrea Maddox-Smith - December 20, 2019

Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer

Peter Hofland, Ph.D - December 3, 2019

Glioblastoma with extreme nuclear enlargement.

Tasadenoturev + Pembrolizumab Shows Clinical Benefit in Recurrent Glioblastoma

Peter Hofland, Ph.D - November 24, 2019

Woman with lung cancer during medical visit

WCLC 2019: Updates from the Pembrolizumab Clinical Development Program

Peter Hofland, Ph.D - August 26, 2019

Human kidney cross section. Photo courtesy: 2019 Fotolia

Europe Adopts Pembrolizumab + Axitinib as First-Line Treatment for Advanced Renal...

Peter Hofland, Ph.D - July 29, 2019

Pembrolizumab + Chemotherapy meets Primary Endpoint in Pivotal Phase III Trial...

Peter Hofland, Ph.D - July 29, 2019

12 3 Page 1 of 3

LATEST NEWS

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Danielle Garcia - June 16, 2020

Press Releases | Cancer

Reaction from Cory Watson Attorneys: $10 Billion Settlement Reached in... July 1, 2020
Bayer, the maker of weed killer Roundup, will pay more than $10 billion to resolve thousands of lawsuits regarding claims that its product causes cancer. Monsanto lost its first three Roundup trials...(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/reaction_from_cory_watson_attorneys_10_billion_settlement_reached_in_roundup_weed_killer_cancer_litigation/prweb17229746.htm
Silicon Beach-Based Nonprofit Startup Cure Glioblastoma Launches... July 1, 2020
Internal research programs to focus on building combination immunotherapies for brain cancer(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/silicon_beach_based_nonprofit_startup_cure_glioblastoma_launches_laboratory_operations_and_appoints_drs_john_boockvar_and_lisa_haile_as_senior_fellows/prweb17226957.htm
Lumeda Announces Formation of its Scientific Advisory Board July 1, 2020
Prominent medical and scientific experts to help company advance development of PDT products.(PRWeb July 01, 2020)Read the full story at https://www.prweb.com/releases/lumeda_announces_formation_of_its_scientific_advisory_board/prweb17222019.htm
Latest Data on IO Combinations Will Be Announced at the IO... June 30, 2020
IO Combinations 360°, organized by the Conference Forum, a combination-specific program, reports on the latest data and advancements to expedite more accurate therapies for patients faster taking...(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/latest_data_on_io_combinations_will_be_announced_at_the_io_combinations_360_conference_october_1_2_2020/prweb17225687.htm
Flagship Biosciences Launches New Clinical Diagnostics Service June 30, 2020
TissueInsight Immuno-Oncology Service Offers Data for Advanced Cancer Patient Care(PRWeb June 30, 2020)Read the full story at https://www.prweb.com/releases/flagship_biosciences_launches_new_clinical_diagnostics_service/prweb17223687.htm
AltruBio Inc. presented AbGn-107 Phase 1a chemo-refractory GI cancer... June 29, 2020
AltruBio Inc. http://www.altrubio.com, a clinical stage biotech company, has announced the presentation of AbGn-107 at the 2020 ASCO GI Cancer...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/altrubio_inc_presented_abgn_107_phase_1a_chemo_refractory_gi_cancer_results_at_asco_gi_2020/prweb17222550.htm
Dimensional Insight Announces Registration Sponsorship of St. Jude... June 29, 2020
Event benefits kids with childhood cancer, other life-threatening diseases at St. Jude Children’s Research Hospital(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/dimensional_insight_announces_registration_sponsorship_of_st_jude_walk_run_boston/prweb17222315.htm
iRECIST Criteria: An Operational Approach in Oncology Clinical Trials,... June 29, 2020
In this free webinar, the featured speakers will discuss concepts of establishing iUPD and iCPD by category and data scenarios across imaging time point visits. Attendees will learn about image case...(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/irecist_criteria_an_operational_approach_in_oncology_clinical_trials_upcoming_webinar_hosted_by_xtalks/prweb17222231.htm
The Lymphoma Research Foundation Hosts Inaugural Swirl: America, An At... June 29, 2020
LRF Spokesperson and Acclaimed Journalist Lisa Guerrero Kicks Off Nationwide Cheeseboard Challenge to Drive Lymphoma Awareness(PRWeb June 29, 2020)Read the full story at https://www.prweb.com/releases/the_lymphoma_research_foundation_hosts_inaugural_swirl_america_an_at_home_tasting_virtual_fundraiser/prweb17222149.htm
Managing Abnormal Results on Cervical Cancer Screening: ASCCP Issues... June 28, 2020
Published in Journal of Lower Genital Tract Disease, New Recommendations Focus on More Personalized Risk Assessment and Management(PRWeb June 28, 2020)Read the full story at https://www.prweb.com/releases/managing_abnormal_results_on_cervical_cancer_screening_asccp_issues_updated_guidelines/prweb17219257.htm
New US Patent Protects Key Element of First-in-Class Prodrug Candidate... June 26, 2020
Tumor-targeting and tumor-penetrating peptide enables EnduRx Pharmaceuticals novel prodrug for triple-negative breast cancer(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/new_us_patent_protects_key_element_of_first_in_class_prodrug_candidate_for_triple_negative_breast_cancer/prweb17214155.htm
PathAI and Bristol Myers Squibb find positive association of digital... June 26, 2020
Digital analysis shows higher sensitivity for PD-L1 expression and accurate detection of low-level PD-L1 expression in patients compared to manual reading(PRWeb June 26, 2020)Read the full story at https://www.prweb.com/releases/pathai_and_bristol_myers_squibb_find_positive_association_of_digital_pd_l1_expression_with_outcomes_in_nivolumab_treated_patients_in_an_exploratory_analysis/prweb17220807.htm
Lumeda Enters License Agreement with Roswell Park Comprehensive Cancer... June 25, 2020
Company secures exclusive rights for intraoperative photodynamic therapy in the treatment of non-small cell lung cancer(PRWeb June 25, 2020)Read the full story at https://www.prweb.com/releases/lumeda_enters_license_agreement_with_roswell_park_comprehensive_cancer_center/prweb17218726.htm
Texas Breast Cancer Survivor Launches Experiential Website to Help... June 25, 2020
It would take Stage 3 Breast Cancer in 2011 for Stephanie Johnson to consider cannabis. Now, having survived longer than anticipated, she hopes to help others feel more comfortable, too.(PRWeb June 25, 2020)Read the full story at https://www.prweb.com/releases/texas_breast_cancer_survivor_launches_experiential_website_to_help_others_searching_for_quality_hemp_cbd_information/prweb17211906.htm

Tag: pembrolizumab

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Potential Accelerated Approval Enfortumab Vedotin + Pembrolizumab in Metastatic Urothelial Cancer

Combination Enfortumab Vedotin + Pembrolizumab Granted Breakthrough Therapy in Bladder Cancer

Enfortumab Vedotin + Pembrolizumab Shrink Tumors in the Majority of Bladder...

FDA Approves Novel Treatments for Metastatic Urothelial Cancer – But More...

Enfortumab Vedotin + Pembrolizumab to be Evaluated in Metastatic Bladder Cancer

Tasadenoturev + Pembrolizumab Shows Clinical Benefit in Recurrent Glioblastoma

WCLC 2019: Updates from the Pembrolizumab Clinical Development Program

Europe Adopts Pembrolizumab + Axitinib as First-Line Treatment for Advanced Renal...

Pembrolizumab + Chemotherapy meets Primary Endpoint in Pivotal Phase III Trial...

LATEST NEWS

Positive CHMP Opinion for Samsung Bioepis’ Bevacizumab Biosimilar Candidate

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

AACR 2020: Positive Preclinical Safety and Efficacy Data for TXR-311 in HCC

Public-private Partnership to Improve Outcomes for Veterans at Risk of Lung Cancer

Positive CHMP Opinion for Samsung Bioepis’ Bevacizumab Biosimilar Candidate

New Therapies may Offer Hope for Patients with Metastatic Breast Cancer

Pembrolizumab Approved for Treatment Advanced Cutaneous Squamous Cell Carcinoma

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...